Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Goldman Sachs Maintains Neutral on IDEXX Laboratories, Raises Price Target to $610

Goldman Sachs maintains IDEXX Laboratories (NASDAQ:IDXX) with a Neutral and raises the price target from $550 to $610.
byBenzinga Newsdesk
August 3, 2021
1 minute read
Total
0
Shares
0
0
0
0
0
0

Goldman Sachs maintains IDEXX Laboratories (NASDAQ:IDXX) with a Neutral and raises the price target from $550 to $610.

 
Total
0
Shares
Share 0
Tweet 0
Share 0
Share 0
Share 0
Share 0
Related Posts